Almotriptan

Active ingredient description

Almotriptan is a selective 5-HT1B and 5-HT1D receptor agonist. These receptors mediate vasoconstriction of certain cranial vessels, as demonstrated in studies using isolated human tissue preparations.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
N02CC05
Almotriptan
N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC05

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
ALMOGRAN Film-coated tablet
Summary of Product Characteristics (SPC)
UK

Medicines

Almotriptan is the active ingredient of these drugs:

Drug
Countries
ALMOGRAN

Finland France Germany Ireland Italy

ALMOTREX

Italy

ALMOZEN

Poland

AMIGNUL

Spain

RIPTANAX

Spain

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₁₇H₂₅N₃O₂S
Molecular mass: 335.464 g/mol

External identifiers

CAS Substance: 154323-57-6
DrugBank Drug: DB00918
PubChem Compound: 123606
RxNorm Ingredient: 279645
SNOMED-CT Concept: 363569003
Almotriptan (substance)
UNII Identifier: 1O4XL5SN61
ALMOTRIPTAN
 
Next: Usage >